Hello {{first_name | AI enthusiast}}

S&P Global supercharges Capital IQ Pro with ProntoNLP sentiment analysis, expanded fixed income data, and Drift AI acquisition, while MeMed’s BV Flex blood test snags FDA breakthrough status for bacterial-viral detection, and AI precision medicine rockets to $125.81B by 2040. These moves rewrite financial modeling and diagnostics.

Scroll down to catch the signals that matter.

S&P Global enhances its Capital IQ Pro platform by integrating ProntoNLP for advanced sentiment analysis, adding comprehensive fixed income, biopharma, and private markets data, plus acquiring Drift AI to enable sophisticated AI-powered financial modeling and predictive insights for investors and analysts worldwide.

Financial pros gain edge in real-time decision-making.

Raoul Pal interviews Martin DeVido on Anthropic’s Claude AI model, which autonomously grows a tomato plant by integrating sensors, cameras, and decision-making algorithms to monitor soil, light, water, and nutrients, demonstrating practical agentic AI applications in agriculture and hinting at scalable autonomous systems for food production.

Agentic AI edges toward real-world farming revolutions.

A Senate Committee hearing spotlights health data policy and AI governance, emphasizing standardized APIs for seamless patient data access, interoperability standards, and regulatory frameworks to balance innovation with privacy, ensuring equitable healthcare delivery amid rising AI diagnostics.

Standardized APIs could unlock patient-centered AI health tech.

Nine Entertainment Co. selects the Domo platform to create a unified AI and data foundation, consolidating disparate sources for enterprise-wide analytics, real-time insights, and AI-driven content optimization to streamline operations across media production and audience engagement.

Media giants unify data for AI-fueled audience mastery.

New York’s Algorithmic Pricing Disclosure Act now requires businesses using personal data in algorithm-based pricing to disclose these practices, aiming to curb discriminatory dynamic pricing in e-commerce, rentals, and services while empowering consumers with visibility into AI-driven decisions.

Consumers demand accountability in AI price algorithms.

ResearchAndMarkets forecasts the AI in precision medicine market surging to $125.81 billion by 2040 at a 28% CAGR, fueled by genomics, personalized therapies, and machine learning for targeted treatments in oncology, rare diseases, and chronic conditions.

Tailored therapies set to dominate healthcare economics.

The FDA grants breakthrough device designation to MeMed BV Flex, a machine learning blood test that accurately distinguishes bacterial from viral infections, enabling precise antibiotic prescribing, reducing overuse, and improving patient outcomes in emergency and primary care settings.

AI diagnostics slash antibiotic resistance risks.

Analysis warns that China’s bulk data rule heightens compliance and litigation risks for global firms, complicating data governance interpretations around pixel tracking, cross-border transfers, and national security reviews in digital advertising and analytics ecosystems.

Multinationals face intensified data sovereignty battles.

Washington’s HB 1170 mandates AI developers to embed provenance data in generated media like deepfakes and images, promoting transparency, combating misinformation, and enabling verification tools for elections, journalism, and social platforms.

Provenance tech builds trust in AI content.

Florida’s House scales back transparency in its data center bill, permitting non-disclosure agreements for up to one year on incentives and operations, prioritizing economic growth over public scrutiny in AI infrastructure deals.

States balance growth with data center secrecy.

—

What trends are you tracking? Reply with your take or forward to a colleague shaping AI strategy.